Program Book - Confex

ACR/ARHP Poster Session C
2388. Gender-Specific Differences in Adamantiades-Behçet’s
Disease Presentation and Their Relationship with HLA-B5:
An Analysis of 731 Subjects From the German Registry for
Adamantiades-Behçet’s Disease. Nikolaos G. Bonitsis 1 , Liem
Binh Luong Nguyen 2 , Nestor Papoutsis 1 , Andreas Altenburg 1 ,
Ina Kötter 3 , Alfred Mahr 2 and Christos C. Zouboulis 1 ,
1
Departments of Dermatology, Venereology, Allergology
and Immunology, Dessau Medical Center, Dessau, Germany,
2
Department of Internal Medicine, Hospital Saint-Louis,
Paris, France, 3 Department of Internal Medicine II,
Rheumatology Division, University Hospital Tübingen,
Tübingen, Germany
2389. Exploration of Male Gender in Heterogeneity of
Association Between HLA-B51/B5 and Behçet’s Disease
Using Mixture Models. Michael P. LaValley 1 , Hailong
Cheng 2 , Mathilde de Menthon 3 and Alfred Mahr 3 , 1 Boston
University School of Public Health, Boston, MA, 2 Sunovion
Pharmaceuticals Inc., Marlborough, MA, 3 Hospital Saint-
Louis, Paris, France
2390. CC Chemokine RECEPTOR 5 POLYMORPHISM In BEHÇET’S
DISEASE. Fabiola Atzeni 1 , Luigi Boiardi 2 , Bruno Casali 3 ,
Enrico Farnetti 3 , Piercarlo Sarzi-Puttini 1 , Nicolo Pipitone 2 ,
Ignazio Olivieri 4 , Fabrizio Cantini 5 , Fabrizio Salvi 6 , Renato
La Corte 7 , Giovanni Triolo 8 , Davide Filippini 9 , Giuseppe
Paolazzi 10 and Carlo Salvarani 2 , 1 Rheumatology Unit, L.
Sacco University Hospital of Milan, Milan, Italy, 2 Arcispedale
S Maria Nuova, Reggio Emilia, Italy, 3 Molecular Biology
Laboratory, Arcispedale S. Maria Nuova,, Reggio Emilia, Italy,
4
Rheumatology Department of Lucania, San Carlo Hospital
of Potenza and Madonna delle Grazie Hospital of Matera,
Potenza, Italy, 5 Stabilimento Ospedaliero Misericordia,
Prato, Italy, 6 Dept. of Neurological Sciences, Ospedale
Bellaria,, Bologna, Italy, 7 Chair of Rheumatology, University
of Ferrara,, Ferrara, Italy, 8 Rheumatology Unit, University
of Palermo, Palermo, Italy, 9 Rheumatology Unit, Ospedale
Niguarda,, Milan, Italy, 10 Ospedale Santa Chiara, Trento
2391. Genome-Wide Expression Profiling of CD14+ Monocytes
in Behcet’s Disease: An Upregulated TGF-b Signaling
and N-Methyltransferase Activity. M. Dozmorov 1 , F.
Ozdemir 2 , V. Yilmaz 3 , E. Eksioglu-Demiralp 2 , J. Wren 1 , G.
Saruhan-Direskeneli 3 , A. Sawalha 1 and H. Direskeneli 4 ,
1
Department of Medicine, University of Oklahoma
Health Sciences Center, Oklahoma City, OK, 2 Marmara
University, School of Medicine, Department of Immunology,
Istanbul, Turkey, 3 Istanbul University, Istanbul Faculty of
Medicine, Department of Physiology, Istanbul, Turkey,
4
Marmara University, School of Medicine, Department of
Rheumatology, Istanbul, Turkey
2392. Parvovirus B19 in Behçet’s Disease. Zahra Habibagahi,
Mojtaba Habibagahi and Said Mostafa Said Mardani, Shiraz
University of Medical Sciences, Shiraz, Iran
2393. Management and Prognosis of Non- Pulmonary Large
Arterial Disease in Behcet’s Syndrome: A Reappraisal of 25
Patients From a Single Center. Hasan Tuzun, Emire Seyahi,
Caner Arslan, Vedat Hamuryudan, Kazim Besirli and Hasan
Yazici, University of Istanbul, Cerrahpasa Medical Faculty,
Istanbul, Turkey
2394. Long-Term Outcome of Arterial Lesions in Behçet’s Disease:
A Series of 101 Patients. David Saadoun 1 , B. Asli 2 , Bertrand
Wechsler 2 , Habib Houman 3 , Guillaume Geri 2 , Jean-Charles
Piette 2 , Zahir Amoura 2 , Mathieu Resche Rigon 1 and Patrice
Cacoub 2 , 1 Department of Internal Medicine and Laboratory
I3 “Immunology, Immunopathology, Immunotherapy”,
UMR CNRS 7211, INSERM U959, Groupe Hospitalier Pitié-
Salpetrière, Université Pierre et Marie Curie, Paris 6 , Paris,
France, Paris, France, 2 CHU Pitié-Salpêtrière, Paris, France,
3
department of internal medicine hôpital la rabta Tunis
Tunisie, France
2395. Immunosuppressants Reduce Venous Thrombosis Relapses
in Behçet‘s Disease. anne Claire Desbois 1 , Bertrand
Wechsler 2 , Jean-Charles Piette 3 , Du Boutin 1 , Zahir Amoura 4 ,
Fabien Koskas 1 , Patrice Cacoub 4 and David Saadoun 5 ,
1
Department of Internal Medicine and 2Laboratory I3 «
Immunology, Immunopathology, Immunotherapy », UMR
CNRS 7211, INSERM U959, Groupe Hospitalier Pitié-
Salpetrière, Université Pierre et Marie Curie, Paris 6 , Paris,
France, Paris, France, 2 Hopital de la Pitie, Paris, France,
3
Paris, 4 CHU Pitié-Salpêtrière, Paris, France, 5 Department
of Internal Medicine and Laboratory I3 “Immunology,
Immunopathology, Immunotherapy”, UMR CNRS 7211,
INSERM U959, Groupe Hospitalier Pitié-Salpetrière,
Université Pierre et Marie Curie, Paris 6, Paris, France, Paris,
France
2396. Difference of Manifestations and Treatment Among
Behcet’s Syndrome Patients in the United States and
Japan. Yuri Ohara 1 , Mitsumasa Kishimoto 1 , Tatsuo
Kobayashi 2 , Christopher Swearingen 3 , M.T. Filopoulos 4 ,
Yasuharu Tokuda 5 , Hideto Oshikawa 2 , Kazuki Yoshida 2 ,
Masako Utsunomiya 2 , Makiko Kimura 2 , Masato Okada 1 ,
Kazuo Matsui 2 and Yusuf Yazici 6 , 1 St. Luke’s International
Hospital, Tokyo, Japan, 2 Kameda Medical Center, Kamogawa
City, Japan, 3 University of Arkansas for Medical Sciences,
Little Rock, AR, 4 Hospital for Joint Diseases, New York,
NY, 5 University of Tsukuba, Ibaraki, Japan, 6 Division of
Rheumatology, New York University School of Medicine and
NYU Hospital for Joint Diseases, New York, NY
2397. Neuro-Behçet´s Disease in Brazil: Higher Incidence in
Females and Atypical Manifestations. Livia A. Dutra 1 , Celio
R. Gonçalves 2 , José L. Pedroso 1 , Pedro Braga-Neto 1 , Alberto
A. Gabbai 1 , Orlando G. P. Barsottini 1 and Alexandre W. S.
de Souza 1 , 1 Universidade Federal de São Paulo, São Paulo,
Brazil, 2 Universidade de São Paulo, São Paulo, Brazil
2398. Some Manifestations Disappear Earlier Than Others in
Behcet’s Syndrome. F. Sevgi Sacli 1 , Emire Seyahi 2 , Serdal
Ugurlu 3 , Yilmaz Ozyazgan 2 , Cem Mat 2 and Hasan Yazici 2 ,
1
Cerrahpasa Medical Faculty, University of Istanbul, Istanbul,
Turkey, 2 University of Istanbul, Cerrahpasa Medical Faculty,
Istanbul, Turkey, 3 Rheumatology, Istanbul, Turkey
2011 Program Book 301